Amarna Therapeutics

The R&D team of Amarna Therapeutics has a long standing expertise in virology, molecular biology, immunology, cell biology and is highly experienced in molecular cloning activities, tissue culture of mammalian cells and production of (recombinant) virus particles in mammalian cell systems. Amarna Therapeutics has an extensive expertise in entrepreneurial activities and is well-experienced with the major business issues such as IP, technology, legal, finance and business strategy. In order to execute our 3 years long SVac therapeutic vaccination R&D program a consortium has been formed that consists of prestigious universities and companies.